News

2018-08-21

A platform for new biologics and technology innovations

A high-quality, pilot-scale biopharmaceutical manufacturing facility is now opening in Uppsala, Sweden. The new Testa Center at GE Healthcare is both a national and an international test bed for start-up companies working with technology- and biologics innovations, as well as for the bioprocess industry. Ilya Pharma will be one of the first companies to use the bioprocess equipment.


2018-05-21

Ilya Pharma welcomes a new project manager to the team

Peter Frank now fills the position as Drug Development manager at Ilya Pharma. Peter has a background in the industry of more than fifteen years working with development of biologics. Previous recent positions were at GE Healthcare and Galderma.


2018-05-16

Ilya Pharma is selected finalist for SwedenBIO Award 2018

SwedenBIO's prize is awarded to a Life Science company that demonstrated successful achievements beyond the usual and that has contributed to increased interest in the industry. This year Ilya Pharma is selected as finalist together with Bioarctic, Galenica, Gedea Biotech, Hansa Medical, Isconova/Novavax, Scandinavian Biopharma, Verigraft, Wilson Therapeutics and Xintela. The jury consists of SwedenBIO's Board and a representative of the year's price sponsor HealthCap.


2018-03-26

Export in the hot spot

Evelina Vågesjö participated in a panel discussion with Ann Linde, Sweden´s Minister of EU affairs and trade. The subject was how to strengthen the export potential in the business region Uppsala.


2018-03-08

Female entrepreneurs leading the way

Five promising entrepreneurs from the Nordic countries was selected to participate in a global conference in New York, between the 4th and 9th of March. The focus was how to build a sustainable global company according to the goals UN Development and Sustainability Objectives 2030.